WallStreetZenWallStreetZen

NASDAQ: EVO
Evotec Se Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

EVO past revenue growth

How has EVO's revenue growth performed historically?
Company
-2.97%
Industry
36.52%
Market
17.66%
EVO's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
EVO's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance

EVO earnings and revenue history

Current Revenue
$844.1M
Current Earnings
-$98.6M
Current Profit Margin
-11.7%

EVO Return on Equity

Current Company
-8%
Current Industry
13.6%
Current Market
25.1%

Be the first to know when EVO announces earnings.

EVO Return on Assets

Current Company
-4%
Current Industry
3.5%

EVO Return on Capital Employed

Current Company
-5.05%
Current Industry
5.8%

EVO vs Pharmaceutical Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
EVON/AN/AN/A+99.41%N/A
ANIP$538.95M$118.65M$25.39M+20.17%-4.43%
COLL$576.65M$363.60M$99.89M+14.49%-14.87%
INDV$1.15B-$126.00M-$141.00M+14.36%N/A
AVDL$95.15M-$95.46M-$106.22M+4.95%N/A
View Top Pharmaceutical Stocks

EVO earnings dates

Next earnings date
Nov 6, 2024

Evotec Se Earnings & Revenue FAQ

What were EVO's earnings last quarter?

On Invalid Date, Evotec Se (NASDAQ: EVO) reported Q1 2024 earnings per share (EPS) of -$0.07, up 51.16% year over year. Total Evotec Se earnings for the quarter were -$22.47 million. In the same quarter last year, Evotec Se's earnings per share (EPS) was -$0.04.

If you're new to stock investing, here's how to buy Evotec Se stock.

What was EVO's earnings growth in the past year?

As of Q3 2024, Evotec Se's earnings has grown year over year. Evotec Se's earnings in the past year totalled N/A.

What is EVO's earnings date?

Evotec Se's earnings date is Invalid Date. Add EVO to your watchlist to be reminded of EVO's next earnings announcement.

What was EVO's revenue last quarter?

On Invalid Date, Evotec Se (NASDAQ: EVO) reported Q1 2024 revenue of $226.88 million up 2.26% year over year. In the same quarter last year, Evotec Se's revenue was $232.13 million.

What was EVO's revenue growth in the past year?

As of Q3 2024, Evotec Se's revenue has grown -2.97% year over year. This is 39.48 percentage points lower than the US Drug Manufacturers - Specialty & Generic industry revenue growth rate of 36.52%. Evotec Se's revenue in the past year totalled N/A.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.